A 66-year-old woman with diabetes, coronary disease, orthostatic hypotension, and the nephrotic syndrome

New England Journal of Medicine

Volumn 342, Issue 4, 2000, Pages 264-273

  Davies, T Q ^a   Fing, M E ^a   Smith, R N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUDROCORTISONE; FUROSEMIDE; GUANETHIDINE; HYDRALAZINE; INSULIN; LEVOTHYROXINE; POTASSIUM CHLORIDE; TORASEMIDE;

AGED; AMYLOIDOSIS; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HUMAN; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SYSTEMIC DISEASE;

EID: 0343775717     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200001273420408     Document Type: Article

References (49)

1. Kushwaha SS, Fallon JT, Fustcr V. Restrictive cardiomyopathy. N Engl J Med 1997;336:267-76.
2. Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb-Peploe MM. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 1991;18:1230-5.
3. Anvari A, Graninger W, Schneider B, Sochor H, Weber H, Schmidinger H. Cardiac involvement in systemic sclerosis. Arthritis Rheum 1992;35: 1356-61.
4. Challenor VF, Conway N, Monro JL. The surgical treatment of restrictive cardiomyopathy in pseudoxanthoma elasticum. Br Heart J 1988;59:266-9.
5. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994;8:65-73.
6. Paillorle C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol 1989;64:1010-6.
7. Sharma O, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253-8.
8. Sharma OP. Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 1997;18:813-25.
9. Oakley CM. Cardiac sarcoidosis. Thorax 1989;44:371-2.
10. Fleming HA. Cardiac sarcoidosis. Semin Respir Med 1986;8:65-71.
11. Winters S, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.
12. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977;63:86-108.
13. Valantine H, McKenna WJ, Nihoyannopoulos P, et al. Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987;57: 256-63.
14. Lewin RF, Mor R, Spitzer S, Arditti A, Hellman C, Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-22.
15. Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989;63:478-82.
16. Liu P, Olivieri N. Iron overload cardiomyopathics: new insights into an old disease. Cardiovasc Drugs Ther 1994;8:101-10.
17. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909.
18. Kyle RA. Amyloidosis. Circulation 1995;91:1269-71.
19. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59.
20. Arbustini E, Merlini G, Gavazzi A, et al. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J 1995;130:528-36.
21. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983;52:137-46.
22. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-55.
23. Naggar CZ. Rapid amyloid infiltration of the heart. Am J Med 1986; 80:276-8.
24. Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1989;13:1017-26.
25. Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;16:1135-41.
26. Ridolfi RL, Bulkley BH, Hutchins GM. The conduction system in cardiac amyloidosis: clinical and pathologic features of 23 patients. Am J Med 1977;62:677-86.
27. Mathew V, Olson LJ, Gertz MA, Hayes DL. Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol 1997;80:1491-2.
28. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J 1995;74:541-4.
29. Smith RR, Hutchins GM. Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 1979;44:413-7.
30. Plehn JF, Friedman BJ. Diastolic dysfunction in amyloid heart disease: restrictive cardiomyopathy or not? J Am Coll Cardiol 1989;13:54-6.
31. Daubert JP, Gaede J, Cohen HJ. A fatal case of constrictive pericarditis due to a marked, selective pericardial accumulation of amyloid. Am J Med 1993;94:335-40.
32. Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol 1982;49: 9-13.
33. Falk RH, Plehn JF, Derring T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59: 418-22.
34. Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985;6:737-43.
35. Hamer JP, Janssen S, van Rijswijk MH, Lie KI. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J 1992;13:623-7.
36. Gertz MA, Kyle RA. Primary systemic amyloidosis - a diagnostic primer. Mayo Clin Proc 1989;64:1505-19.
37. Pellikka PA, Holmes DR Jr, Edwards WD, Nishimura RA, Tajik AJ, Kyle RA. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 1988;148:662-6.
38. Crotty T, Li C, Edwards W, Suman V. Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. Cardiovasc Pathol 1995;4:39-42.
39. Duston MA, Skinner M, Shirahama T, Cohen AS. Diagnosis of amyloidosis by abdominal fat aspiration: analysis of four years' experience. Am J Med 1987;82:412-4.
40. Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study. Circulation 1991;83:808-16.
41. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658 64.
42. Patel AR, Dubrey SW, Mendes LA, et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol 1997;80:486-92.
43. Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 1997;80:1242-5.
44. Dubrey SW, Bilazarian S, LaValley M, Reisinger J, Skinner M, Falk RH. Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. Am Heart J 1997;134:994-1001.
45. Olson LJ, Gertz MA, Edwards WD, et al. Senile cardiac amyloidosis with myocardial dysfunction: diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Mcd 1987;317:738-42.
46. Kyle RA, Spittell PC, Gertz MA, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101: 395-400.
47. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol 1997;99:245-56.
48. Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990;75:531-45.
49. Cueto-Garcia L, Tajik AJ, Kyle RA, et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 1984;59:589-97